HPV
Abbott RealTime High Risk HPV
For more information, contact Abbott.
For more information, contact Abbott.
PRODUCT NAME | UNIT SIZE | ORDER NUMBER | GTIN |
---|
The Abbott RealTime High Risk (HR) HPV assay detects 14 high-risk HPV genotypes with simultaneous identification of HPV 16 and HPV 18. (02N09-90)
02N09-92 has the following additional intended use:
To learn more about Abbott RealTime High Risk HPV please visit: https://www.molecular.abbott/int/en/products/infectious-disease/realtime-high-risk-hpv
ABBOTT REALTIME HIGH RISK HPV | |
Instrumentation | Extraction: m2000sp, m24; Amplification and Detection: m2000rt |
Kit Configuration | 4 x 24 tests/kits |
Technology | Multiplex real-time PCR |
Assay Performance | Clinical Sensitivity and Specificity in Referral Population: High Risk HPV Detection Clinical Sensitivity: 97.5%**; Clinical Specificity: 99.4%** |
HPV High Risk Detection | 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 |
HPV Genotyping | HPV 16, HPV 18 |
Sample Type | ThinPrep® PreservCyt® Solution (Hologic, Inc.) SurePath® Preservative Fluid® (Becton, Dickinson and Company) and post-gradient cell pellet dilution Abbott Cervi-Collect Specimen Collection Kit |
Input Volume | 400 ul |
Internal Control | An endogenous human beta globin sequence in detected as sample validity control for cell adequacy, sample extraction and amplification efficiency |
External Controls | Negative control; Positive control |
Reported Results | Qualitative detection of 14 High Risk HPV types, typing of HPV 16 and/or HPV 18, single and mixed infections |
** Package Insert
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.